• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

需要透析的肾功能障碍是一种异质综合征:我们应该像对待一种疾病那样对待它。

Kidney dysfunction requiring dialysis is a heterogeneous syndrome: we should treat it like one.

机构信息

Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem.

University of North Carolina (UNC) Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, UNC School of Medicine.

出版信息

Curr Opin Nephrol Hypertens. 2022 Jan 1;31(1):92-99. doi: 10.1097/MNH.0000000000000754.

DOI:10.1097/MNH.0000000000000754
PMID:34846314
Abstract

PURPOSE OF REVIEW

Advanced kidney failure requiring dialysis, commonly labeled end-stage kidney disease or chronic kidney disease stage 5D, is a heterogeneous syndrome -a key reason that may explain why: treating advanced kidney dysfunction is challenging and many clinical trials involving patients on dialysis have failed, thus far. Treatment with dialytic techniques - of which maintenance thrice-weekly hemodialysis is most commonly used - is broadly named kidney 'replacement' therapy, a term that casts the perception of a priori abandonment of intrinsic kidney function and subsumes patients into a single, homogeneous group.

RECENT FINDINGS

Patients with advanced kidney failure necessitating dialytic therapy may have ongoing endogenous kidney function, and differ in their clinical manifestations and needs. Different terminology, for example, kidney dysfunction requiring dialysis (KDRD) with stages of progressive severity could better capture the range of phenotypes of patients who require kidney 'assistance' therapy.

SUMMARY

Classifying patients with KDRD based on objective, quantitative levels of endogenous kidney function, as well as patient-reported symptoms and quality of life, would facilitate hemodialysis prescriptions tailored to level of kidney dysfunction, clinical needs, and personal priorities. Such classification would encourage clinicians to move toward personalized, physiological, and adaptive approach to hemodialysis therapy.

摘要

目的综述

需要透析的晚期肾衰竭,通常被标记为终末期肾病或慢性肾脏病 5 期,是一种异质性综合征——这可能是迄今为止治疗晚期肾功能障碍具有挑战性且许多涉及透析患者的临床试验都失败的一个关键原因。使用透析技术进行治疗——其中最常用的是每周三次维持性血液透析——通常被称为肾脏“替代”治疗,该术语暗示了对固有肾功能的先验放弃,并将患者归入一个单一的、同质的群体。

最新发现

需要透析治疗的晚期肾衰竭患者可能仍有内源性肾功能,且临床表现和需求存在差异。例如,使用不同的术语,如需要透析的肾功能障碍(KDRD)及其进展严重程度的分期,可能更能捕捉需要肾脏“辅助”治疗的患者的表型范围。

总结

根据内源性肾功能的客观、定量水平以及患者报告的症状和生活质量对 KDRD 患者进行分类,将有助于根据肾功能障碍程度、临床需求和个人优先事项来定制血液透析处方。这种分类将鼓励临床医生采用个性化、生理性和适应性的血液透析治疗方法。

相似文献

1
Kidney dysfunction requiring dialysis is a heterogeneous syndrome: we should treat it like one.需要透析的肾功能障碍是一种异质综合征:我们应该像对待一种疾病那样对待它。
Curr Opin Nephrol Hypertens. 2022 Jan 1;31(1):92-99. doi: 10.1097/MNH.0000000000000754.
2
The spectrum of kidney dysfunction requiring chronic dialysis therapy: Implications for clinical practice and future clinical trials.需要长期透析治疗的肾功能不全谱:对临床实践和未来临床试验的启示。
Semin Dial. 2022 Mar;35(2):107-116. doi: 10.1111/sdi.13027. Epub 2021 Oct 12.
3
Patient-reported outcomes in a pilot clinical trial of twice-weekly hemodialysis start with adjuvant pharmacotherapy and transition to thrice-weekly hemodialysis vs conventional hemodialysis.在一项每周两次起始的血液透析联合辅助药物治疗并过渡至每周三次血液透析与传统血液透析的先导性临床试验中患者报告的结局。
BMC Nephrol. 2022 Sep 27;23(1):322. doi: 10.1186/s12882-022-02946-w.
4
Short, thrice-weekly hemodialysis is inadequate regardless of small molecule clearance.无论小分子清除情况如何,每周三次的短程血液透析都是不够的。
Int J Artif Organs. 2004 Jun;27(6):452-66. doi: 10.1177/039139880402700603.
5
[Renal replacement therapy by hemodialysis: an overview].[血液透析的肾脏替代治疗:概述]
Nephrol Ther. 2009 Jul;5(4):306-12. doi: 10.1016/j.nephro.2009.03.001. Epub 2009 May 28.
6
Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline.透析开始时间、血液透析治疗次数和频率以及膜通量:一项用于 KDOQI 临床实践指南的系统评价。
Am J Kidney Dis. 2015 Nov;66(5):823-36. doi: 10.1053/j.ajkd.2014.11.031.
7
The ABCs of personalized incremental dialysis start, Le Mans style.个体化递增透析的 Le Mans 式起点:ABC 方案。
J Nephrol. 2022 Dec;35(9):2417-2423. doi: 10.1007/s40620-022-01507-6. Epub 2022 Nov 18.
8
Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review.血液透析、腹膜透析和肾移植治疗的成年人的生活参与活动比较:系统评价。
Am J Kidney Dis. 2013 Nov;62(5):953-73. doi: 10.1053/j.ajkd.2013.03.022. Epub 2013 May 29.
9
Problems and solutions for artificial kidney.人工肾的问题与解决方案
Technol Health Care. 2000;8(6):373-9.
10
Initiating renal replacement therapy through incremental haemodialysis: Protocol for a randomized multicentre clinical trial.递增式血液透析启动肾脏替代治疗的随机多中心临床试验方案
Trials. 2020 Feb 19;21(1):206. doi: 10.1186/s13063-020-4058-0.

引用本文的文献

1
Patient, Nurse, and Physician Perspectives on Personalized, Incremental Hemodialysis.患者、护士和医生对个性化、渐进性血液透析的看法。
J Am Soc Nephrol. 2024 Oct 1;35(10):1442-1445. doi: 10.1681/ASN.0000000000000467. Epub 2024 Aug 12.
2
Residual Kidney Function in Hemodialysis: Its Importance and Contribution to Improved Patient Outcomes.血液透析患者的残余肾功能:其重要性及其对改善患者预后的贡献。
Toxins (Basel). 2024 Jun 28;16(7):298. doi: 10.3390/toxins16070298.
3
Longitudinal Changes in Kidney Solute Clearance in a Prospective Cohort of Patients Initiating Chronic Hemodialysis.
开始进行慢性血液透析的前瞻性队列患者肾脏溶质清除率的纵向变化
Kidney Int Rep. 2024 Mar 13;9(6):1774-1782. doi: 10.1016/j.ekir.2024.03.015. eCollection 2024 Jun.
4
Living Well With Kidney Disease and Effective Symptom Management: Consensus Conference Proceedings.《肾病患者的健康生活与有效症状管理:共识会议记录》
Kidney Int Rep. 2022 Jun 30;7(9):1951-1963. doi: 10.1016/j.ekir.2022.06.015. eCollection 2022 Sep.
5
Does delivering more dialysis improve clinical outcomes? What randomized controlled trials have shown.提供更多的透析治疗能改善临床结局吗?随机对照试验的结果表明。
J Nephrol. 2022 Jun;35(5):1315-1327. doi: 10.1007/s40620-022-01246-8. Epub 2022 Jan 18.